<DOC>
	<DOCNO>NCT00964912</DOCNO>
	<brief_summary>The purpose study determine safety tolerability BMS-820836 single dos</brief_summary>
	<brief_title>Single Dose Study BMS-820836</brief_title>
	<detailed_description />
	<criteria>Body Mass Index ( BMI ) 18 30 kg/m2 , inclusive weight ≥ 50 kg Righthanded , nonambidextrous subject Part 2 Men woman , age 18 55 year , inclusive Women child bear potential ( WOCBP ) unwilling unable use acceptable method avoid pregnancy entire study period 8 week last dose investigational product WOCBP use prohibit contraceptive method Women pregnant breastfeed Sexually active fertile men use effective birth control partner WOCBP Any significant acute chronic medical illness Current recent ( within 3 month ) gastrointestinal disease History cholecystectomy Any major surgery within 4 week study drug administration Any gastrointestinal surgery could impact absorption study drug Donation blood plasma blood bank clinical study ( except screen visit ) within 4 week study drug administration Blood transfusion within 4 week study drug administration Inability tolerate/swallow oral medication Difficulty venipuncture and/or poor venous access Selfreported smoker Recent ( within 1 year ) psychostimulant use ( cocaine , methylphenidate , amphetamine , ecstasy ) Confirmed rest supine systolic blood pressure &gt; 130 mmHg Confirmed rest supine diastolic blood pressure &gt; 80 mmHg Confirmed QT value ≥ 500 msec Confirmed QTc ( Bazett ) value ≥ 450 msec History significant drug allergy ( anaphylaxis hepatotoxicity ) History peppermint allergy History brain condition ( e.g . history stroke , head trauma , etc . ) History current psychiatric condition History claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>